{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T21:11:23Z","timestamp":1790457083797,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.jval.2020.04.002","type":"journal-article","created":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T05:00:16Z","timestamp":1600059616000},"page":"1128-1136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":118,"title":["Improving Transparency to Build Trust in Real-World Secondary Data Studies for Hypothesis Testing\u2014Why, What, and How: Recommendations and a Road Map from the Real-World Evidence Transparency Initiative"],"prefix":"10.1016","volume":"23","author":[{"given":"Lucinda S.","family":"Orsini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Crown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Georg","family":"Eichler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Goettsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Graff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Guerino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pall","family":"Jonsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirosha Mahendraratnam","family":"Lederer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitta","family":"Monz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Daniel","family":"Mullins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Schneeweiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Van","family":"Brunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley V.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Willke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7272","key":"10.1016\/j.jval.2020.04.002_bib1","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1136\/bmj.321.7272.1300","article-title":"Accountability for reasonableness","volume":"321","author":"Daniels","year":"2000","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.jval.2020.04.002_bib3","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jval.2016.12.003","article-title":"Policies for use of real-world data in health technology assessment (HTA): a comparative study of six HTA agencies","volume":"20","author":"Makady","year":"2017","journal-title":"Value Health"},{"issue":"3","key":"10.1016\/j.jval.2020.04.002_bib4","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jval.2017.08.3013","article-title":"Real-world evidence: useful in the real world of US payer decision making? How? When? And what studies?","volume":"21","author":"Malone","year":"2018","journal-title":"Value Health"},{"issue":"8","key":"10.1016\/j.jval.2020.04.002_bib8","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.jval.2017.08.3018","article-title":"Reporting to improve reproducibility and facilitate validity assessment for healthcare database studies V1.0","volume":"20","author":"Wang","year":"2017","journal-title":"Value Health"},{"issue":"7","key":"10.1016\/j.jval.2020.04.002_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001671","article-title":"Improving the transparency of prognosis research: the role of reporting, data sharing, registration, and protocols","volume":"11","author":"Peat","year":"2014","journal-title":"PLoS Med"},{"issue":"3","key":"10.1016\/j.jval.2020.04.002_bib10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3325\/cmj.2010.51.191","article-title":"Comparative effectiveness research: challenges for medical journals","volume":"51","author":"Sox","year":"2010","journal-title":"Croat Med J"},{"issue":"9","key":"10.1016\/j.jval.2020.04.002_bib11","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/pds.4297","article-title":"Good practices for real-world data studies of treatment and\/or comparative effectiveness: Recommendations from the joint ISPOR-ISPE Special Task Force on real-world evidence in health care decision making","volume":"26","author":"Berger","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"10","key":"10.1016\/j.jval.2020.04.002_bib13","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.12869","article-title":"Feasibility of using real-world data to replicate clinical trial evidence","volume":"2","author":"Bartlett","year":"2019","journal-title":"JAMA Network Open"},{"issue":"2","key":"10.1016\/j.jval.2020.04.002_bib14","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1046\/j.1524-4733.2003.00242.x","article-title":"A\u00a0checklist for retrospective database studies--report of the ISPOR Task Force on Retrospective Databases","volume":"6","author":"Motheral","year":"2003","journal-title":"Value Health"},{"issue":"8","key":"10.1016\/j.jval.2020.04.002_bib15","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/j.1524-4733.2009.00600.x","volume":"12","author":"Berger","year":"2009","journal-title":"Value Health"},{"issue":"8","key":"10.1016\/j.jval.2020.04.002_bib16","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1524-4733.2009.00601.x","volume":"12","author":"Cox","year":"2009","journal-title":"Value Health"},{"issue":"8","key":"10.1016\/j.jval.2020.04.002_bib17","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1524-4733.2009.00602.x","volume":"12","author":"Johnson","year":"2009","journal-title":"Value Health"},{"issue":"2","key":"10.1016\/j.jval.2020.04.002_bib18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jval.2013.12.011","article-title":"A\u00a0questionnaire to assess the relevance and credibility of observational studies to inform health care decision making: an ISPOR-AMCP-NPC Good Practice Task Force report","volume":"17","author":"Berger","year":"2014","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.jval.2020.04.002_bib19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/pds.3891","article-title":"Guidelines for good pharmacoepidemiology practice (GPP)","volume":"25","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"10.1016\/j.jval.2020.04.002_bib25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jclinepi.2012.05.011","article-title":"GRADE guidelines-an introduction to the 10th-13th articles in the series","volume":"66","author":"Guyatt","year":"2013","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.jval.2020.04.002_bib26","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1017\/S0266462317004408","article-title":"Peer-reviewed journal editors\u2019 views on real-world evidence","volume":"34","author":"Oehrlein","year":"2018","journal-title":"Intl. J of Technology Assessment in Health Care"},{"issue":"15","key":"10.1016\/j.jval.2020.04.002_bib27","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1503\/cmaj.092252","article-title":"Registration of observational studies: is it time?","volume":"182","author":"Williams","year":"2010","journal-title":"CMAJ"},{"issue":"10","key":"10.1016\/j.jval.2020.04.002_bib29","first-page":"1107","article-title":"The GRACE checklist: a validated assessment tool for high quality observational studies of comparative effectiveness","volume":"22","author":"Dreyer","year":"2016","journal-title":"J\u00a0Manag Care Spec Pharm"},{"key":"10.1016\/j.jval.2020.04.002_bib30","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.jval.2020.04.002_bib31","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/pds.4381","article-title":"Strengthening standards, transparency, and collaboration to support medicine evaluation: ten years of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP)","volume":"27","author":"Kurz","year":"2018","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"10.1016\/j.jval.2020.04.002_bib32","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/pds.4442","article-title":"Reuse of data sources to evaluate drug safety signals: when is it appropriate?","volume":"27","author":"Wang","year":"2018","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"7","key":"10.1016\/j.jval.2020.04.002_bib33","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/pds.4004","article-title":"Evidence generation from healthcare databases: recommendations for managing change","volume":"25","author":"Bourke","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109830152030190X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109830152030190X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:20:04Z","timestamp":1761096004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109830152030190X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S109830152030190X"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2020.04.002","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improving Transparency to Build Trust in Real-World Secondary Data Studies for Hypothesis Testing\u2014Why, What, and How: Recommendations and a Road Map from the Real-World Evidence Transparency Initiative","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2020.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 ISPOR-The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}